Health Insurance Innovations (NASDAQ:HIIQ) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Monday, April 2nd.
Other research analysts also recently issued reports about the company. Canaccord Genuity reaffirmed a “buy” rating and set a $39.00 price target on shares of Health Insurance Innovations in a report on Friday, December 22nd. BidaskClub raised Health Insurance Innovations from a “hold” rating to a “buy” rating in a report on Friday, December 15th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $38.00 price target on shares of Health Insurance Innovations in a report on Tuesday, December 12th. Zacks Investment Research raised Health Insurance Innovations from a “hold” rating to a “buy” rating and set a $31.00 price target on the stock in a report on Thursday, January 25th. Finally, B. Riley initiated coverage on Health Insurance Innovations in a report on Tuesday, February 13th. They set a “buy” rating and a $38.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. Health Insurance Innovations currently has an average rating of “Buy” and a consensus target price of $42.62.
Health Insurance Innovations stock traded up $0.25 during mid-day trading on Monday, hitting $28.75. The company had a trading volume of 274,537 shares, compared to its average volume of 406,218. Health Insurance Innovations has a 12 month low of $12.65 and a 12 month high of $37.38. The company has a market capitalization of $473.96, a price-to-earnings ratio of 23.96 and a beta of 0.41.
Health Insurance Innovations (NASDAQ:HIIQ) last released its earnings results on Wednesday, February 28th. The financial services provider reported $0.37 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.34 by $0.03. Health Insurance Innovations had a return on equity of 21.27% and a net margin of 7.14%. The business had revenue of $69.50 million for the quarter, compared to the consensus estimate of $59.93 million. Health Insurance Innovations’s revenue for the quarter was up 35.2% compared to the same quarter last year. equities analysts expect that Health Insurance Innovations will post 1.95 EPS for the current fiscal year.
In related news, insider Sheldon Wang sold 30,000 shares of the company’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $30.49, for a total transaction of $914,700.00. Following the completion of the sale, the insider now owns 94,001 shares in the company, valued at $2,866,090.49. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In the last quarter, insiders have sold 40,000 shares of company stock valued at $1,215,200. 30.00% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently modified their holdings of the business. MetLife Investment Advisors LLC purchased a new stake in Health Insurance Innovations in the fourth quarter worth about $144,000. The Manufacturers Life Insurance Company increased its position in Health Insurance Innovations by 7,616.4% in the second quarter. The Manufacturers Life Insurance Company now owns 8,951 shares of the financial services provider’s stock worth $210,000 after buying an additional 8,835 shares in the last quarter. SG Americas Securities LLC purchased a new stake in Health Insurance Innovations in the fourth quarter worth about $238,000. Advisors Asset Management Inc. purchased a new stake in Health Insurance Innovations in the third quarter worth about $142,000. Finally, American Century Companies Inc. purchased a new stake in Health Insurance Innovations in the fourth quarter worth about $276,000. Institutional investors and hedge funds own 79.22% of the company’s stock.
Health Insurance Innovations Company Profile
Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provides three months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.